Avalon Global Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-76,600
Closed -$4.82M 45
2020
Q1
$4.54M Hold
76,600
2.14% 22
2019
Q4
$5.69M Sell
76,600
-23,400
-23% -$1.64M 1.23% 16
2019
Q3
$6.31M Hold
100,000
2.16% 14
2019
Q2
$5.45M Buy
+100,000
New +$5.39M 2.57% 15
2019
Q1
Sell
-72,300
Closed -$4.46M 34
2018
Q4
$4.74M Sell
72,300
-47,700
-40% -$3.56M 2.88% 15
2018
Q3
$9.45M Hold
120,000
3.26% 9
2018
Q2
$7.72M Buy
120,000
+70,000
+140% +$4.61M 2.81% 12
2018
Q1
$3.11M Buy
+50,000
New +$3.59M 1.07% 47

Other funds holding CVS

Avalon Global Asset Management's CVS Position: Q2 2020 in Review

Avalon Global Asset Management sold out of CVS Health (CVS) in Q2 2020, closing a stake of 76,600 shares — an estimated $4.82M sold.

Avalon Global Asset Management first reported a position in CVS in Q1 2018 and held it in 8 quarters. The position peaked at $9.45M in Q3 2018. 1,863 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Avalon Global Asset Management reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Avalon Global Asset Management sold 76,600 CVS Health shares in Q2 2020, an estimated $4.82M.
  • Avalon Global Asset Management first reported a position in CVS Health in Q1 2018 and held it in 8 quarters.
  • Avalon Global Asset Management's CVS Health position peaked at $9.45M in Q3 2018.
  • 1,863 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Avalon Global Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.